KT-579
KT579-HV-101
Phase 1 small_molecule active
Quick answer
KT-579 for Healthy Participants is a Phase 1 program (small_molecule) at Kymera Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kymera Therapeutics
- Indication
- Healthy Participants
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active